Downloading...
Download

GWPH

Long GWPHUrg.. tradingview decided to hide a lot of my previous idea because I didn't go pro, what a scam. If you like my charts and would like to support me going pro for $12.95, please msg me so i can keep sending out these ideas weekly. TradingView Open position at $182 Stop loss at $180 Take profit at $187 Why this play? Gwph had a pretty good earning but got beaten down due to market conditions. they had a lot of upgrades with price range of $200+ the last few days but they can't move with market uncertainty. AS soon as market runs, they will fly, but ofc that will depend on market.
GLong
by WallSt007
Healthy consolidation for ZYNEIt would seem that ZYNE got a bit ahead of itself. We were very extended on 26, 29 and 30 April, and finally saw some healthy consolidation with an initial 5% pull back. SPY was making ripples yesterday, and probably added much to panic reaction, more than 20% down. I bought that dip with much gratitude, and relished when buying pressure forced her back up to $11.40. If we assume that the recent high of $13.06 marks the end of this cycle, we'll probably see some lower highs and lower lows/higher lows, leading the price back to the 45 degree line, most likely keeping the range roughly between $10 and $12 for now. On the other hand, if bulls break the $13 price resistance, we'll see another leg up. Perhaps that is why we always say "levels on watch". I expect the 45 degree trend line to be strong, as it has been 'touched' 3 times. Keep in mind that ZYNE is only just starting on its rebound journey upward. If you think you've missed it, I think you're wrong. I think the entry is now, with targets of $15 within weeks, and $25 and $36 within the next 6 to 8 months. What we're hoping to see from ZYNE, is a great Phase 3 trial results, and for the broader market, the legalisation of CBD as an additive, etc. so that Zynerba can start marketing its wide range of unique patents. When that bit is behind us, CBD legalisation in the European Union is next. Also for GWPH, btw. Safe trading, everybody!
Z
by Barkworth
ZYNE, when and how...Zynerba is one of my favourite biopharma stocks. I've played her from $3.88 up to $5.22, then sold when I saw that the hype was temporarily over. I didn't want to go long ZYNE, because biopharma is some scary stuff. When they presented failed trials earlier, the stock plunged 53%. On the other hand, when a trial succeeds, and a medicine can be filed and prepped for marketing, it is a potential almost without limits. ZYNE has a patent gel, which is important, because it is hard to get CBD into your body if you don't want to smoke or eat it. I was just looking at GW PHarma... Second one out, first one with epilepsy medicine... Zynerba is expected to break even this year. Current trial phases are published on their website. Short term, I don't see much of a bullish trend, just investors getting on board at specific publications. My plan is to wait for it to reach, what I see as, the buy zone. I'm planning to take a moderate position there.
Z
by Barkworth
GTEC - 200 ema entry point?Dear Traders, A little update on the GTEC stock. Our MACD shows us a Bullish Continuing Divergence, which is a bullish sign. This combined with the 200 ema being close, I'm expecting a bounce off from that 200 ema located at 1.08$. This might be a very good entry point in my opinion, but, if you are entering I would choose your stoploss carefully. I'm saying this because on a GTEC Bullboard, i saw some negative messages coming by such as : ''recent press release said they lost an expansion because the city voted no. also they just applied for an alberta sales license, I work for the AGLC, this process takes 4 months.'' People are saying it's price will drop under 1$ blablabla... This could be to create FUD, so that they can buy cheaper. I'm only relying on TA. Fud is something you come across on each forum about a stock unfortunately.. I didnt find any official press release backing up the negativity this person said on the bullboard so let's see how this plays off.
G
by Raw_Blitz
GWPH - Technical AnalysisDear Traders, GWPH, also known as GGW Pharmaceuticals plc (GWPH), has been following its bullish Channel pretty well. Thos I don't really know if im Bullish or Berish for now. We have good volume, we are in a bullish channel, but we are under the 1H 55 ema (Blue line). If resistance at the 55 ema holds, we will see a bit more retracing, but if we succeed in buying that resistance, i'll be 100% bullish. About GWPH : GW Pharmaceuticals plc researches and develops cannabinoid prescription medicines for the treatment of cancer pain, Multiple Sclerosis, and neuropathic pain. Latest News: finance.yahoo.com
G
by Raw_Blitz
GWPH pushing higher earlier than expectedI expected action like this next week. If we close above 124 I would imagine we trend towards the high before the 19th and possibly reach or breach thereafter depending one the news. As you can see we are in the lower half of the bullish channel which should give it plenty of room to run if we break that Fib. Which I think we will, due to timing before the news announcement on the 19th. Of course this is all opinion and just ideas for you to judge for yourself. Good luck out there.
GLong
by mycoinmoon
Shaping the Future - an analysis on GWPHGood Afternoon and welcome to an analysis on GWPH. Looking at the chart we can see that GWPH broke through the support line on 2/22 and is now testing it as the current Major Resistance line. We have fallen to the Major Support line on 3/2 and bounced back up to touch the resistance line again. We almost looked as though we were going to break into the resistance line however all indicators show we are heading back down, at least for the short time. Looking at the DMI the +DM and the -DM touched briefly on 3/9 but then like a magnet split away from each other. The ADX is still above a 25 (barely), but nevertheless it is still above the signal line showing we are in a strong trend, and that current trend has been bearish. Plus the RSI hit my projected downward line and turned to head back south helping to confirm we indeed could drop further. The MACD is relatively flat and has turned up but it is still below out signal line as well. From the looks of the chart at the moment we could definitely head back down to touch the support line again. A good entry point would be between $109 and $111 with placing a stop loss just below the support line to minimize loss. Since Sep. of 2016 we have been in a trading range from roughly $95 - $140. Currently we are on the lower end of that spectrum. My personal opinion, with more doors opening for the legalization of marijuana in different states in the US and in other countries, I believe this GWPH is a good long hold. They have an A+ team, and I believe they will shape the future of cannabis-based therapeutics. Happy Trading :) Much Love DustyPH *all comments are welcome* ***This information is not a recommendation to buy or sell***
GLong
by dustyPH
AMMJ Target 5.00 (Very high net profit margins+growth) #MJ Quarterly Semi-Annual Annual (Values in 000s | USD) Period Ending Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Total Revenue 990 952 617 339 Cost of Revenue 163 133 146 106 Gross Profit 826 819 470 233 Operating Expenses Research and Development 63 0 0 0 Sales, General and Admin. 435 478 679 413 Non-Recurring Items - - - - Other - - - - Operating Income 317 329 (214) (189) Income From Continuing Operations Add'l Income/Expense Items - - 8 (40) Earnings Before Interest and Tax 317 329 (214) (189) Interest Expense - - 0 - Earnings Before Tax 317 329 (206) (235) Income Tax - 0 0 - Minority Interest - - - - Equity Earnings Unconsolidated Subsidiary - - - - Net Income Cont. Operations 317 329 (206) (235) Non Recurring Events Discontinued Operations - - - - Extraordinary Items - - - - Effect of Accounting Changes - - - - Other Items - - - - Net Income 317 329 (206) (235) Preferred Stock and Other Adjustments - - - - Net Income Applicable to Common Shareholders 317 329 (206) (235) Assets Current Assets Cash and Cash Equivalents 1,877 1,675 1,663 751 Short Term Investments - - - - Net Receivables 404 193 117 164 Inventory 30 25 28 42 Other Current Assets 14 17 19 9 Total Current Assets 2,326 1,912 1,828 967 Long Term Investments - - - - Property Plant and Equipment 12 8 10 11 Goodwill - - - - Intangible Assets - - - - Accumulated Amortization - - - - Other Assets 4 4 59 4 Deferred Long Term Asset Charges - - - - Total Assets 2,344 1,925 1,898 983 Liabilities Current Liabilities Accounts Payable 34 130 228 92 Short Term and Current Long Term Debt - - - 0 Other Current Liabilities 57 12 434 222 Total Current Liabilities 92 142 663 329 Long Term Debt - - - - Other Liabilities - - - - Deferred Long Term Liability Charges - - - - Minority Interest - - - - Negative Goodwill - - - - Total Liabilities 92 142 663 329 Stockholders' Equity Misc. Stock Options Warrants - - - - Redeemable Preferred Stock - - - - Preferred Stock 0 0 - 0 Common Stock 0 0 0 0 Retained Earnings (4,235) (4,611) (4,940) (4,734) Treasury Stock - - - - Capital Surplus 6,486 6,393 6,176 5,389 Other Stockholder Equity - - - - Total Stockholder Equity 2,251 1,783 1,235 654 Net Tangible Assets 2,251 1,783 1,235 654
OTC:AMMJLong
by StockPicksNYC98
UPDATE: GWPH GAMECHANGER IN CANNABOID MARKETUPDATE:GWPH WILL IT EVER STOP RISING.... STUCK IN CHANNEL ON AN UPTREND AND NEWS CONSTANTLY REITERATING THE TECHNICAL BACKING.... EVERY MORNING THE STOCK TRADES HIGHER DUE TO MONSTER NEWS COMING FROM UK AND THIS STOCK IS A PIONEER TO A BUDDING MEDICAL MARIJUANA MARKET COMING TO THE STATES. STRONG BUY DESPITE THE STOCK BEING I THE 100+ CATEGORY.... THIS IS JUST THE START, HOWEVER A STOP LOSS OF 90.4256 THE 20 EMA WOULD BE A GREAT IDEA TO CAP YOUR DOWNSIDE IF YOU CHOOSE TO BUY INTO THIS STOCK THIS FAR ALONG.
GLong
by bhorbs81